FLT1 and acute myeloid leukemia: Also, inhibition of off-target tyrosine kinases that circumvent FLT3 inhibitors should be detected, such as FLT1, FLT4, PDGFRα, and PDGFRβ (like compound 27), to elucidate the efficacy of these novel FLT3 inhibitors versus resistant AML cells.